Answers are grounded in this paper and cite their sources.
Intracerebral hemorrhage (ICH) is a rare but potentially severe neurological complication of polycythemia or erythrocytosis. This systematic review aimed to characterize the clinical features, underlying hematological disorders, potential contributing factors, management strategies, and outcomes of reported cases. PubMed, Scopus, and ScienceDirect were searched from inception through July 2026 in accordance with PRISMA guidelines. Seven individual case reports comprising seven patients were included. Patients ranged from 2 to 76 years of age, and five (71.4%) were male. Underlying disorders included polycythemia vera, post-polycythemia vera myelofibrosis, secondary hypoxia-induced erythrocytosis, mixed-etiology erythrocytosis, unclassified polyglobulia, and congenital erythrocytosis associated with high-oxygen-affinity hemoglobin variants. Five patients experienced recurrent or multiple ICH, involving both deep and lobar brain regions. Coexisting factors included hyperviscosity, severe hypoxemia, hypertension, smoking, thrombocytopenia, platelet dysfunction, and vascular abnormalities. Management included therapeutic phlebotomy or venesection, cytoreductive therapy, supportive neurological and hemostatic treatment, antihypertensive therapy, risk-factor modification, and neurosurgical intervention. Four patients survived with clinical improvement, two died following progressive or recurrent hemorrhage, and one had an unreported outcome. The available case reports suggest a multifactorial association but do not establish an independent causal role for erythrocytosis. Further observational studies are needed to clarify recurrence risk and optimal management strategies.
No takes yet. Share an insight, caveat, or question.
Faisol et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: